mikesassa

[mikesassa]

Multi-state operators, or MSO’s, have long represented the biggest and most influential cannabis players in North America. Yet, as that market matures and expansion opportunities dwindle a new trend is emerging – the rise of ‘multi-country operators’ (MCOs).

[mikesassa]

For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the market evolves, established cannabis brands are playing an increasingly critical role in patient care, physician confidence, and regulatory acceptance, mirroring the progression of traditional pharmaceuticals.

[mikesassa]

Global medical cannabis markets are exploding, and the patients exploring cannabis as an alternative therapy are more diverse than ever. Both doctors and cannabis cultural leaders are working to bring education to new demographics.

[mikesassa]

The global cannabis industry saw an incredible end to 2024. Q4 2024 showed that the international medical cannabis explosion is here as global markets topped three billion euros! 

[mikesassa]

Thailand has become the fastest-growing internal cannabis market, potentially netting $1.2 billion in internal sales in 2025. Thailand’s cannabis products could provide a massive export opportunity for the global markets in Europe.

PACCAN GROUP, Asia’s leading plant-based biotechnology company, and SOMAÍ Pharmaceuticals, one of Europe’s most influential medical cannabis companies, have partnered to create a cross-continental powerhouse that will bring PACCAN’s products to Europe and SOMAÍ’s products to Asia. This partnership represents the best of Thailand and Europe’s cannabis industries coming together to produce and distribute medical cannabis properly, safely, and ethically in the global markets.

[mikesassa]

2025 is poised for a massive explosion in the global medical cannabis market. Many politicians and regulators have been grappling for years with the best way to legalize and distribute cannabis to their population. Now, it's clearer than ever that science and popular opinion agree that cannabis is safer than many current pharmaceuticals and tens of millions of people around the world have found comfort in cannabis for what ails them.

[mikesassa]

Medical cannabis markets around the world are starting to show signs of early United States and Canadian-style progressions.

Consumer flower trends have moved toward much higher-quality and higher-potency cultivars. The extract market is starting to differentiate with more and more product choices and higher performance. Additionally, dispensaries are now beginning to emerge worldwide.

Patients increasingly prefer to visit U.S.-style dispensaries where the staff is knowledgeable about cannabis rather than relying solely on their general practitioner’s advice. In the U.S., a good budtender knows that finding the right product for you can make the difference between effective therapy and enjoyable consumption, and they help customers make an informed choice.